OTCMMCOA
Market cap19kUSD
Dec 23, Last price
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-100.00%
Name
Marijuana Company Of America Inc
Chart & Performance
P/E
—
P/S
0.02
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
189.25%
Revenues
990k
-3.88%
Net income
-14m
L-1.53%
CFO
-2m
L-44.27%
Profile
Marijuana Company of America, Inc., together with its subsidiaries, develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand name in the United States. The company offers hempSMART products comprising hempSMART Brain, a patented and formulated personal care consumer product for brain wellness; hempSMART Pain capsules for temporary relief of minor discomfort with physical activity; hempSMART Pain Cream to reduce minor discomfort and promote muscle relaxation; hempSMART Drops, a hemp CBD oil tincture drops; hempSMART Pet Drops for cats and dogs; hempSMART Face, a facial moisturizer; and hempSMART drink mix, an industrial hemp based powderized CBD drink through its web site and affiliate marketing programs. It also distributes hemp and CBD products, such as smoke and vape shop related products to wholesalers, c-stores, specialty retailers, and consumers through www.cdistro.com. The company was formerly known as Converge Global, Inc. and changed its name to Marijuana Company of America, Inc. in December 2015. Marijuana Company of America, Inc. was incorporated in 1985 and is based in Los Angeles, California.
IPO date
Mar 21, 2000
Employees
7
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
| Income | |||||||||
Revenues | 990 -3.88% | 1,030 267.09% | |||||||
Cost of revenue | 1,724 | 5,640 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (734) | (4,610) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 5 | 4,302 | |||||||
Tax Rate | |||||||||
NOPAT | (734) | (8,912) | |||||||
Net income | (14,271) -1.53% | (14,494) -4.30% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 1,188 | 2,202 | |||||||
BB yield | -95.82% | -34.96% | |||||||
| Debt | |||||||||
Debt current | 5,084 | 3,789 | |||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 5,084 | 1,358 | |||||||
| Cash flow | |||||||||
Cash from operating activities | (2,220) | (3,984) | |||||||
CAPEX | (126) | ||||||||
Cash from investing activities | 20 | (217) | |||||||
Cash from financing activities | 2,117 | 4,242 | |||||||
FCF | 1,981 | (13,357) | |||||||
| Balance | |||||||||
Cash | 104 | ||||||||
Long term investments | 2,327 | ||||||||
Excess cash | 2,380 | ||||||||
Stockholders' equity | (8,856) | (89,378) | |||||||
Invested Capital | 5,024 | 93,398 | |||||||
ROIC | |||||||||
ROCE | 19.15% | ||||||||
| EV | |||||||||
Common stock shares outstanding | 12,401,816 | 5,248,076 | |||||||
Price | 0.00 -91.67% | 0.00 -71.01% | |||||||
Market cap | 1,240 -80.31% | 6,298 58.12% | |||||||
EV | 6,336 | 7,668 | |||||||
EBITDA | (622) | (4,508) | |||||||
EV/EBITDA | |||||||||
Interest | 3,694 | 4,302 | |||||||
Interest/NOPBT | |||||||||